1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On July 30, 2025, Harley-Davidson Credit Corp. agreed to sell a portion of its motorcycle loan portfolio, including future originations, to KKR Morrow Trust and Cavendish LLC. The parties estimate about $4 billion in net cash proceeds to the unit, with closing expected around October 2025 and no later than January 31, 2026. The deal also brings outside investors into Harley-Davidson Financial Services, which will issue equity equal to 9.8% of its common stock.
Estimated net cash proceeds of approximately $4 billion, with closing expected around October 2025 and no later than January 31, 2026
Forward flow agreements commit each buyer to purchase up to $1 billion of new motorcycle contracts annually for a minimum of five years from closing
Minority investors KKR-OpCoAgg and Cavendish will pay $46.6 million in cash for a combined 9.8% stake in Harley-Davidson Financial Services
Buyers may terminate if Harley-Davidson Financial Services' net worth falls below $40 million
Chemours reported second quarter 2025 net sales of $1.6 billion, up 4% from a year earlier, but swung to a net loss of $381 million, or $2.54 per diluted share, from net income of $60 million a year earlier. The company said the loss was driven mainly by litigation charges tied to its New Jersey PFAS settlement, while adjusted net income rose to $87 million, or $0.58 per share.
Net sales were $1.6 billion, up 4% from $1,554 million in Q2 2024
Net loss attributable to Chemours was $381 million, or $2.54 per diluted share, versus net income of $60 million, or $0.39, in Q2 2024
Adjusted net income was $87 million, or $0.58 per diluted share, versus $58 million, or $0.38, a year earlier
Full-year 2025 Adjusted EBITDA is expected to be $775 million to $825 million, and Q3 2025 Adjusted EBITDA $175 million to $195 million
GXO Logistics said its Chief Financial Officer, Baris Oran, will leave the company in March 2026, under an agreement reached by the company and Mr. Oran on August 4, 2025. He will remain CFO until his departure or until a successor is appointed, and the filing does not name a successor.
Baris Oran will depart as Chief Financial Officer in March 2026, by mutual agreement dated August 4, 2025.
Mr. Oran stays in the CFO role until he leaves or a successor is appointed.
Severance under the Company's Severance Plan and outplacement services are subject to a separation agreement with a general release of claims.
Outstanding service-based and earned performance-based RSUs will vest pro rata through the termination date.
RingCentral reported second-quarter 2025 results on August 5, 2025, with total revenue up 5% to $620 million and GAAP net income of $13.2 million, compared with a net loss a year earlier. The company raised its full-year 2025 non-GAAP EPS and free cash flow guidance while reiterating its revenue growth guidance. The filing also states that Vaibhav Agarwal was promoted to chief financial officer, succeeding Abhey Lamba.
Total revenue of $620 million, up from $593 million a year earlier; subscriptions revenue of $599 million, up 6%.
GAAP operating income of $37 million versus a loss of $5 million a year earlier; GAAP diluted EPS of $0.14 versus ($0.16).
Full-year 2025 non-GAAP EPS range raised to $4.20 to $4.32 from $4.13 to $4.27; free cash flow guidance raised to $515 to $520 million from $500 to $510 million.
Vaibhav Agarwal named CFO; Abhey Lamba stepped down as CFO and will serve as executive advisor through December 31, 2025.
Amentum reported third-quarter fiscal 2025 results for the period ended June 27, 2025, with pro forma revenue up 2% year over year and pro forma Adjusted EBITDA up 7%. The company raised its fiscal 2025 organic revenue guidance and the low end of its Adjusted Diluted EPS guidance, while GAAP results improved from a year earlier largely because of the Jacobs CMS combination.
Q3 revenue was $3.6 billion ($3,561 million), up 2% on a pro forma basis; GAAP revenue rose 66% to $3,561 million from $2,142 million.
Q3 GAAP net income was $10 million, or $0.04 per diluted share, compared with a net loss of $26 million, or $0.29 per share, a year earlier.
Q3 Adjusted EBITDA was $274 million, up 7%, and Adjusted Diluted EPS was $0.56, up from $0.51.
Fiscal 2025 revenue guidance was raised to $13,975 million to $14,175 million from $13,850 million to $14,150 million; Adjusted Diluted EPS guidance low end rose to $2.05 from $2.00.
Noble reported second quarter 2025 total revenue of $849 million, down from $874 million in the first quarter but up from $693 million a year earlier. Net income fell to $43 million, or $0.27 per diluted share, from $108 million in the first quarter and $195 million in the second quarter of 2024. The company lowered its 2025 total revenue guidance to $3,200 million to $3,300 million but raised its Adjusted EBITDA guidance to $1,075 million to $1,150 million.
Q2 2025 total revenue was $849 million, versus $874 million in Q1 2025 and $693 million in Q2 2024.
Q2 2025 net income was $43 million, or $0.27 per diluted share, versus $108 million in Q1 2025 and $195 million in Q2 2024.
2025 total revenue guidance was cut to $3,200 million to $3,300 million from $3,250 million to $3,450 million; Adjusted EBITDA guidance was raised to $1,075 million to $1,150 million from $1,050 million to $1,150 million.
The board approved a $0.50 per share Q3 2025 dividend, payable September 25, 2025, to shareholders of record on September 4, 2025.
Acadia Healthcare reported second-quarter 2025 revenue of $869.2 million, up 9.2% from a year earlier, but net income attributable to the company fell to $30.1 million, or $0.33 per diluted share, from $78.5 million, or $0.85. The company also updated its 2025 guidance and said CFO Heather Dixon will step down effective August 15, 2025, with Senior Vice President Tim Sides named interim CFO effective August 16, 2025.
Q2 2025 revenue $869.2 million, up 9.2%; adjusted EPS $0.83 versus $0.91 in Q2 2024
Net income attributable to Acadia $30.1 million, or $0.33 per diluted share, versus $78.5 million, or $0.85, a year earlier
2025 guidance: revenue $3.3 billion to $3.35 billion; adjusted EPS $2.45 to $2.65; startup losses $60 million to $65 million, a $10 million increase
CFO Heather Dixon resigns effective August 15, 2025; Tim Sides becomes interim CFO effective August 16, 2025 at a $445,000 base salary
Resideo reported second quarter 2025 net revenue of $1.94 billion, up 22% from a year earlier, and adjusted EBITDA of $210 million, up 20%. The company also posted a net loss of $825 million, driven by an $882 million expense tied to its agreement with Honeywell to terminate the Indemnification Agreement, and raised its full-year 2025 outlook. Shareholders will see both the strong operating results and the large one-time charge, with a further one-time payment to Honeywell of $1.59 billion due in the third quarter upon closing.
Net revenue was $1,943 million, up 22% from $1,589 million; adjusted EBITDA was $210 million, up 20% from $175 million.
GAAP diluted loss per share was $(5.59), compared with $0.19 a year earlier; adjusted EPS was $0.66, compared with $0.62.
The net loss reflects an $882 million expense tied to the Honeywell agreement; a $1.59 billion one-time cash payment to Honeywell is due in the third quarter of 2025 upon closing.
The company raised its 2025 outlook, with full-year net revenue now $7,450 million to $7,550 million and adjusted EBITDA of $845 million to $885 million.
Bristow Group reported second quarter 2025 revenues of $376.4 million, net income of $31.7 million, or $1.07 per diluted share, and Adjusted EBITDA of $60.7 million, all up from the first quarter. The company raised its 2025 Adjusted EBITDA outlook to $240 million to $260 million and its 2026 outlook to $300 million to $335 million, and it began accelerated debt payments and share repurchases.
Q2 2025 total revenues were $376.4 million, up from $350.5 million in Q1 2025.
Net income was $31.7 million, or $1.07 per diluted share, compared with $0.92 per diluted share in Q1 2025.
Adjusted EBITDA outlook raised to $240 million to $260 million for 2025 and $300 million to $335 million for 2026.
Repurchased 119,841 shares for $3.9 million and made $15.3 million of accelerated principal payments on its UKSAR Debt facility in the quarter.
IFF reported second-quarter 2025 net sales of $2.76 billion, down 4% from a year earlier, while reported diluted EPS was $2.38 versus $0.66 a year earlier. The company reaffirmed its full-year 2025 guidance, authorized a $500 million share repurchase program with no set end date, and agreed to sell its soy crush, concentrates and lecithin business to Bunge, which the company said generated about $240 million in 2024 revenue. For shareholders, first-half results include a $1,153 million goodwill impairment that produced a $405 million net loss for the six months.
Q2 net sales $2.76 billion, down 4% reported; up 3% on a comparable currency-neutral basis
Q2 reported diluted EPS $2.38 versus $0.66 a year earlier; first-half EPS was a loss of $1.59
Board authorized up to $500 million in share repurchases with no specified term or termination date
Full-year 2025 guidance reaffirmed: sales of $10.6 billion to $10.9 billion and adjusted operating EBITDA of $2 billion to $2.15 billion
ONE Gas reported second-quarter 2025 net income of $32.0 million, or $0.53 per diluted share, up from $27.2 million, or $0.48, a year earlier. It raised its 2025 diluted EPS guidance to $4.32 to $4.42 from $4.20 to $4.32, and declared a $0.67 quarterly dividend, which benefits shareholders by lifting expected full-year earnings.
Q2 2025 net income was $32.0 million, or $0.53 per diluted share, versus $27.2 million, or $0.48, in Q2 2024.
Year-to-date 2025 net income was $151.5 million, or $2.51 per diluted share, versus $126.6 million, or $2.23, in the same period of 2024.
2025 net income guidance was raised to $261 million to $267 million, from $254 million to $261 million.
Board declared a $0.67 per share quarterly dividend, payable September 3, 2025, to holders of record on August 18, 2025.
LeMaitre Vascular reported preliminary second-quarter 2025 results, with net sales of $64.2 million, up 15%, and diluted earnings per share of $0.60, up 16%. The company raised its full-year 2025 sales and earnings guidance, now projecting sales of $248 million to $254 million and diluted EPS of $2.23 to $2.37. The results are preliminary and unaudited.
Q2 2025 gross margin was 70.0%, up from 68.9% a year earlier, and operating income was $16.1 million, up 12%.
Full-year 2025 guidance: sales of $248 million to $254 million and EPS of $2.23 to $2.37.
Q3 2025 guidance: sales of $61.2 million to $63.2 million and EPS of $0.54 to $0.59.
Board approved a $0.20 per share quarterly dividend, payable September 4, 2025, to holders of record on August 21, 2025.
Vestis reported fiscal third-quarter 2025 revenue of $673.8 million, down $24.4 million or 3.5% from a year earlier, and a net loss of $0.7 million, or $(0.01) per diluted share, compared with net income of $5.0 million, or $0.04 per share, in the prior-year quarter. Adjusted EBITDA fell to $64.0 million from $86.9 million, and CEO Jim Barber said results were in line with the company's expectations. Shareholders face lower profit and a narrower margin for covenant compliance, with the Net Leverage Ratio at 4.50x against a 5.25x limit.
Revenue of $673.8 million, down $24.4 million (3.5%) year over year, driven by a $18.0 million decline in rental revenue
Net loss of $0.7 million, or $(0.01) per diluted share, versus net income of $5.0 million, or $0.04 per share, a year earlier
Adjusted EBITDA of $64.0 million versus $86.9 million in the prior-year quarter
Net Leverage Ratio of 4.50x; the credit agreement caps it at 5.25x for quarters ending before July 3, 2026
Gulfport reported second-quarter 2025 net income of $184.5 million, compared with a net loss of $26.2 million a year earlier, on total revenues of $447.6 million. The company also raised its stock repurchase authorization by 50% to $1.5 billion and plans to redeem all outstanding Series A Convertible Preferred Stock for cash on September 5, 2025, while warning that full-year 2025 production is trending toward the low end of its guidance range.
Q2 2025 net income was $184.5 million versus a net loss of $26.2 million in Q2 2024; total revenues were $447.6 million versus $181.1 million.
Full-year 2025 production is now forecast to trend toward the low end of guidance, as midstream capacity projects remain ongoing.
Stock repurchase authorization expanded to $1.5 billion through December 31, 2026; about $790.9 million remains, and 31,356 preferred shares are outstanding for redemption on September 5, 2025.
GXO Logistics reported second quarter 2025 revenue of $3.3 billion, up 16% year over year, and raised its full-year 2025 adjusted EBITDA guidance to $865 million to $885 million. GAAP net income fell to $28 million from $39 million, while adjusted diluted EPS rose to $0.57 from $0.55. CFO Baris Oran also plans to step down, which adds leadership change to the picture for shareholders.
Revenue was $3.3 billion, up 16% from $2.8 billion a year earlier; organic revenue growth was 6%.
Net income was $28 million versus $39 million; diluted EPS was $0.23 versus $0.32. Adjusted diluted EPS was $0.57 versus $0.55.
Full-year 2025 adjusted EBITDA guidance was raised to $865 million to $885 million.
CFO Baris Oran plans to step down to pursue new opportunities and will remain until a successor is named.
Supernus reported second-quarter 2025 total revenues of $165.5 million, down 2% from $168.3 million a year earlier, while diluted earnings per share rose to $0.40 from $0.36 and net earnings were $22.5 million. It raised full-year 2025 revenue guidance to $670 million-$700 million and moved its GAAP operating earnings guidance to a loss of $70 million-$80 million, citing the Sage Therapeutics acquisition completed July 31, 2025. For shareholders, quarterly profit improved, but revenue slipped and the GAAP operating outlook worsened.
Q2 2025 total revenues were $165.5 million, versus $168.3 million in Q2 2024; Qelbree net sales rose 31% to $77.6 million.
Q2 2025 net earnings were $22.5 million, or $0.40 per diluted share, versus $0.36 a year earlier; six-month diluted EPS was $0.19 versus $0.36.
Full-year 2025 total revenue guidance is $670 million-$700 million, up from $600 million-$630 million.
Full-year 2025 GAAP operating earnings (loss) guidance is $(70) million to $(80) million, down from $(15) million to $10 million.
Assurant reported second quarter 2025 GAAP net income of $235.3 million, up 25 percent from $188.7 million a year earlier, and GAAP diluted EPS of $4.56, up from $3.58. The company raised its full-year 2025 outlook, now expecting adjusted EPS excluding reportable catastrophes to approach 10% growth, and plans $250 to $300 million in share repurchases at the upper end of its guidance.
Q2 2025 adjusted EPS was $5.10 versus $4.08; excluding reportable catastrophes, it was $5.56 versus $4.77.
First-half 2025 GAAP net income fell 10 percent to $381.9 million, with reportable catastrophes of $186.8 million pre-tax versus $58.7 million a year earlier.
Global Housing Adjusted EBITDA rose 33 percent to $214.4 million in Q2; Global Lifestyle rose 6 percent to $201.4 million.
Holding company liquidity was $518 million as of June 30, 2025, and $225 million remains under the current repurchase authorization.
News Corp reported fiscal 2025 full-year revenue of $8.45 billion, up 2%, and net income from continuing operations of $648 million, up 71%. The company also announced a new $1 billion stock repurchase program, which adds to about $300 million remaining under an earlier program, and fourth-quarter adjusted EPS of $0.19 compared with $0.20 a year earlier.
Full-year revenue was $8.45 billion, up 2% from $8.25 billion; Total Segment EBITDA was $1.42 billion, up 14%.
Full-year diluted EPS from continuing operations was $0.84 versus $0.47; adjusted diluted EPS was $0.89 versus $0.74.
Fourth-quarter revenue was $2.11 billion, up 1%; quarterly net income from continuing operations was $86 million, up 28%, while adjusted EPS was $0.19 versus $0.20.
A new $1 billion buyback was authorized in July, and a semi-annual dividend of $0.10 per share is payable October 8, 2025.
BlackLine co-founder Therese Tucker will transition from Co-CEO to Founder effective October 1, 2025, and Owen Ryan will serve as sole CEO and Chairman. The company also named David Henshall Lead Independent Director, replacing Tom Unterman, effective August 1, 2025, and Tucker's base salary will decrease to $460,000 while Ryan's will increase to $600,000.
Therese Tucker transitions from Co-CEO to Founder effective October 1, 2025, and remains on the Board and executive team
Owen Ryan becomes sole CEO effective October 1, 2025; his base salary rises to $600,000
Tucker's base salary decreases to $460,000 with an annual target bonus of 80% of base salary
David Henshall replaces Tom Unterman as Lead Independent Director effective August 1, 2025
Equitable Holdings reported a second-quarter 2025 net loss attributable to Holdings of $349 million, or $(1.21) per share, compared with net income of $428 million a year earlier. Non-GAAP operating earnings fell to $352 million, or $1.10 per share, from $495 million, or $1.43 per share, which the company attributed mainly to elevated mortality in its Individual Life block. Shareholders may weigh the July 31 closing of the Individual Life reinsurance deal with RGA, which the company says frees over $2 billion of capital, against the weaker quarterly earnings.
Net loss attributable to Holdings of $349 million, or $(1.21) per share, versus net income of $428 million in Q2 2024.
Non-GAAP operating earnings of $352 million, or $1.10 per share, versus $495 million, or $1.43 per share; $1.41 per share excluding notable items of $95 million.
Individual Life reinsurance transaction with RGA closed July 31, 2025; the company says it frees over $2 billion of capital and reduces mortality exposure by 75%.
The company returned $318 million to shareholders in Q2 and said it expects earnings per share growth to accelerate in the second half of 2025.
Devon Energy reported second-quarter 2025 net earnings of $899 million, or $1.41 per diluted share, up from $494 million, or $0.77 per share, in the first quarter, and raised its full-year 2025 production and oil forecasts. The company also lowered its full-year capital guidance by $100 million and declared a $0.24 per share quarterly dividend, though oil, gas and NGL sales and realized prices fell from the prior quarter.
Net earnings of $899 million ($1.41 per diluted share) and core earnings of $536 million ($0.84 per share) in Q2 2025, versus $494 million ($0.77) in Q1 2025; the quarter included a $307 million gain on asset dispositions.
Q2 production averaged 841,000 Boe per day, above the top end of guidance; full-year 2025 production outlook raised to 825,000-842,000 Boe per day.
Full-year 2025 capital guidance cut to $3.6 billion-$3.8 billion from about $3.8 billion.
Oil, gas and NGL sales were $2.7 billion versus $3.1 billion in Q1 2025, and realized price fell to $36.30 per Boe from $42.45.
DoubleVerify reported second-quarter 2025 revenue of $189.0 million, up 21% from a year earlier, with net income of $8.8 million compared with $7.5 million in the prior-year quarter. The company raised its full-year 2025 revenue growth guidance to approximately 15% and reaffirmed its adjusted EBITDA margin guidance of approximately 32%.
Q2 2025 revenue was $189.0 million, up 21%; Activation revenue rose 25%, Measurement 15%, and Supply-side 26%.
Q2 net income was $8.8 million, or $0.05 per diluted share, versus $7.5 million, or $0.04 per diluted share, a year earlier.
Q2 adjusted EBITDA was $57.3 million, a 30% margin, versus $46.8 million a year earlier.
Third-quarter 2025 guidance calls for revenue of $188 million to $192 million and adjusted EBITDA of $60 million to $64 million.
Toast reported second-quarter 2025 results on August 5, 2025. GAAP net income rose to $80 million from $14 million a year earlier, and Adjusted EBITDA rose to $161 million from $92 million. The company raised its full-year 2025 Adjusted EBITDA outlook to $565 million to $585 million, from $540 million to $560 million.
Q2 2025 total revenue was $1.55 billion, up from $1.24 billion in Q2 2024; GAAP net income was $80 million versus $14 million.
Adjusted EBITDA was $161 million in Q2 2025 versus $92 million in Q2 2024.
Full-year 2025 Adjusted EBITDA outlook raised to $565 million to $585 million, from $540 million to $560 million.
Third-quarter 2025 Adjusted EBITDA is expected in the range of $140 million to $150 million; ARR grew 31% to $1.9 billion as of June 30, 2025.
Aflac reported second-quarter 2025 net earnings of $599 million, or $1.11 per diluted share, down from $1.8 billion, or $3.10 per share, a year earlier. The drop reflects net investment losses of $421 million, while adjusted earnings fell 7.5% to $957 million, so shareholders face lower reported profit even as the company kept its dividend growing and repurchased $829 million of shares.
Total revenues were $4.2 billion, compared with $5.1 billion in the second quarter of 2024.
Adjusted earnings per diluted share decreased 2.7% to $1.78; net investment losses were $421 million.
The board declared a third-quarter dividend of $0.58 per share, payable September 2, 2025.
In the second quarter, Aflac repurchased 7.9 million shares for $829 million, with 30.9 million shares remaining authorized.
Jazz reported second-quarter 2025 total revenues of $1.05 billion, up 2% from a year earlier, but posted a GAAP net loss of $718.5 million after a $905.4 million acquired in-process R&D charge tied to the Chimerix acquisition. The company lowered the top end of its full-year 2025 revenue guidance to $4.15 billion to $4.30 billion and named Renee Gala President and CEO effective August 11, 2025.
Q2 2025 total revenues were $1.05 billion, up from $1.02 billion in Q2 2024.
GAAP net loss was $718.5 million, or $11.74 per diluted share, versus GAAP net income of $168.6 million, or $2.49 per share, in Q2 2024.
The net loss includes a $905.4 million acquired IPR&D charge for dordaviprone, which reduced results by $14.78 per share on a GAAP basis.
2025 total revenue guidance is now $4.15 billion to $4.30 billion, down from $4.15 billion to $4.40 billion at the top end; GAAP net loss guidance is $(565) million to $(450) million.
Teradata reported second-quarter 2025 total revenue of $408 million, down 6% from $436 million a year earlier, and GAAP diluted EPS of $0.09 versus $0.38. The company also set third-quarter and updated full-year 2025 outlook ranges, including a full-year total revenue range of -5% to -7% in constant currency, which shareholders will weigh against the lower current results.
Total revenue was $408 million versus $436 million, down 6% as reported; recurring revenue was $354 million versus $368 million
GAAP diluted EPS was $0.09 versus $0.38; non-GAAP diluted EPS was $0.47 versus $0.64
Third-quarter 2025 outlook: total revenue down 7% to 9% year over year in constant currency; non-GAAP diluted EPS of $0.51 to $0.55
Full-year 2025 outlook: total revenue down 5% to 7% in constant currency; non-GAAP diluted EPS of $2.17 to $2.25; public cloud ARR grew 17% to $634 million
Qualys reported second-quarter 2025 revenue of $164.1 million, up 10% from a year earlier, and GAAP diluted earnings of $1.29 per share, up from $1.17. The company raised its full-year 2025 revenue and per-share earnings guidance, which is favorable for shareholders, though operating cash flow fell 32% in the quarter.
Q2 2025 revenue $164.1 million, up 10% from $148.7 million; GAAP diluted EPS $1.29 vs. $1.17; non-GAAP diluted EPS $1.68 vs. $1.52
Full-year 2025 revenue guidance raised to $656.0 million to $662.0 million from $648.0 million to $657.0 million
Full-year 2025 GAAP EPS guidance raised to $4.47 to $4.77 from $4.27 to $4.57; non-GAAP EPS guidance raised to $6.20 to $6.50 from $6.00 to $6.30
Q2 operating cash flow fell 32% to $33.8 million from $49.8 million
Paylocity reported fiscal 2025 total revenue of $1,595.2 million, up 14%, and GAAP net income of $227.1 million, up 10%, with diluted EPS of $4.02 versus $3.63. Its board also raised the share repurchase authorization by $500 million, on top of $200 million remaining as of June 30, 2025, and the company gave fiscal 2026 total revenue guidance of $1.707 billion to $1.722 billion.
Fiscal 2025 GAAP net income of $227.1 million, or $4.02 per diluted share, versus $206.8 million, or $3.63, in fiscal 2024
Fourth-quarter total revenue of $400.7 million, up 12%; fourth-quarter GAAP net income of $48.6 million, versus $48.8 million a year earlier
Fiscal 2026 total revenue guidance of $1.707 billion to $1.722 billion, about 8% growth over fiscal 2025
Repurchase authorization increased by $500 million, adding to $200 million remaining as of June 30, 2025
Adeia reported second-quarter 2025 revenue of $85.7 million, down from $87.4 million a year earlier and $87.7 million in the first quarter. GAAP diluted EPS rose to $0.15 from $0.07, helped by a $9.1 million income tax benefit, while non-GAAP diluted EPS fell to $0.25 from $0.28, so shareholders see a mixed picture.
Q2 2025 revenue was $85.7 million versus $87.4 million in Q2 2024
GAAP net income was $16.7 million versus $8.4 million a year earlier; non-GAAP diluted EPS was $0.25 versus $0.28
Adjusted EBITDA was $45.7 million versus $52.8 million in Q2 2024
Full-year 2025 GAAP net income outlook raised to $85.1 to $86.5 million from $76.5 to $81.6 million; revenue outlook of $390 to $430 million reiterated
Grocery Outlet reported second quarter fiscal 2025 results for the period ended June 28, 2025, with net sales up 4.5% to $1.18 billion but GAAP net income down to $5.0 million from $14.0 million, weighed by $11.2 million in restructuring charges. The company raised its fiscal 2025 diluted adjusted earnings per share guidance to $0.75 to $0.80 from $0.70 to $0.75 and maintained its other guidance figures, so the profit outlook improved even as reported second quarter earnings declined.
Net sales rose 4.5% to $1.18 billion and comparable store sales increased 1.1%.
Net income was $5.0 million, or $0.05 per diluted share, versus $14.0 million, or $0.14, a year earlier.
Diluted adjusted EPS for fiscal 2025 guidance raised to $0.75 to $0.80 from $0.70 to $0.75; net sales guidance of $4.7 billion to $4.8 billion unchanged.
Restructuring Plan total costs estimated at approximately $63 million, of which approximately $39 million is expected to be cash expenditures.
Advance Auto Parts completed an offering of $975 million of 7.000% notes due 2030 and $975 million of 7.375% notes due 2033, with net proceeds of about $1,920 million. The company plans to use part of the proceeds to redeem its $300 million 5.90% notes due 2026 on August 7, 2025, and expects to enter a new $1.0 billion asset-based revolving credit facility to replace its existing revolver.
Two note series totaling $1.95 billion in principal: $975 million 7.000% notes due 2030 and $975 million 7.375% notes due 2033.
Net proceeds of about $1,920 million, with $300 million earmarked to redeem 5.90% notes due 2026 on August 7, 2025.
Notes were sold to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S; interest is payable semi-annually starting February 1, 2026.
New five-year ABL facility of up to $1,000 million is expected, replacing the existing $1.0 billion revolving credit facility.
Pacira BioSciences reported second-quarter 2025 total revenue of $181.1 million, up from $178.0 million a year earlier, but swung to a GAAP net loss of $4.8 million from net income of $18.9 million. The company narrowed its full-year 2025 revenue guidance to $730 million to $750 million and raised its non-GAAP gross margin guidance to 78 to 80 percent, while non-GAAP net income and adjusted EBITDA both declined year over year.
Total revenue $181.1 million versus $178.0 million in Q2 2024; EXPAREL net product sales $142.9 million.
GAAP net loss of $4.8 million, or $0.11 per share, versus GAAP net income of $18.9 million, or $0.41 per share (basic), in Q2 2024.
Non-GAAP net income $36.0 million, or $0.74 per share (diluted), versus $44.2 million, or $0.89 per share (diluted), a year earlier.
Full-year 2025 revenue guidance narrowed to $730 million to $750 million from $725 million to $765 million; non-GAAP gross margin guidance raised to 78 to 80 percent from 76 to 78 percent.
Standard Motor Products reported second-quarter 2025 net sales of $493.9 million, up 26.7% from a year earlier, and diluted earnings per share from continuing operations of $1.17, up from $0.81. The company raised its full-year 2025 sales growth guidance to the low-20s percent range from its prior mid-teens expectation, and reaffirmed its adjusted EBITDA margin outlook of 10-11%. Excluding the Nissens acquisition, the company said second-quarter sales rose 3.5%.
Net sales were $493.9 million versus $389.8 million in the second quarter of 2024.
GAAP diluted EPS from continuing operations was $1.17 versus $0.81; non-GAAP diluted EPS was $1.29 versus $0.98.
Full-year 2025 sales growth guidance raised to the low-20s percent range, including Nissens; adjusted EBITDA margin outlook of 10-11% reaffirmed.
Quarterly dividend of 31 cents per share, payable September 2, 2025, to holders of record on August 15, 2025.
Otter Tail reported second-quarter 2025 diluted EPS of $1.85, down from $2.07 a year earlier, on revenue of $333.0 million versus $342.3 million. The company raised its 2025 diluted EPS guidance to $6.06 to $6.46 from $5.68 to $6.08, driven by a higher outlook for its Plastics segment, so shareholders face weaker recent quarterly results alongside a higher annual earnings outlook.
Q2 2025 diluted EPS was $1.85 versus $2.07 in Q2 2024; net income was $77.7 million versus $87.0 million.
2025 diluted EPS guidance rose to $6.06 to $6.46 from $5.68 to $6.08, with the Plastics segment guidance raised to $3.64 to $3.88.
Manufacturing net income fell 49.1% to $3.5 million and Plastics net income fell 12.4% to $53.1 million in the quarter.
Board declared a quarterly dividend of $0.525 per share, payable September 10, 2025 to holders of record on August 15, 2025.
Ryman Hospitality Properties reported second quarter 2025 total revenue of $659.5 million, up 7.5% from a year earlier, but net income fell 27.6% to $75.9 million and net income available to common stockholders per diluted share fell 32.1% to $1.12. The company revised its 2025 outlook: the midpoint for net income available to common stockholders per diluted share dropped to $3.47 from $3.93, while the consolidated Adjusted EBITDAre midpoint rose to $790 million from $775 million, reflecting the June 10 acquisition of the JW Marriott Desert Ridge and transient rate risk in Nashville.
Total revenue was $659.5 million, up 7.5%, with Entertainment segment revenue of $143.3 million, an all-time quarterly record.
Net income was $75.9 million, down 27.6%; diluted EPS was $1.12 versus $1.65 a year earlier.
2025 guidance: diluted EPS midpoint lowered to $3.47 from $3.93; consolidated Adjusted EBITDAre midpoint raised to $790 million from $775 million.
Same-store Hospitality Adjusted EBITDAre midpoint cut to $690 million from $695 million; $625 million of 6.500% senior notes due 2033 were sold to help fund the acquisition.
Dana reported second-quarter 2025 continuing-operations sales of $1.95 billion, down from $2.05 billion, while adjusted EBITDA rose to $145 million from $110 million and the pre-tax loss narrowed to $24 million from $53 million. The company raised its full-year 2025 guidance for continuing operations and announced a definitive agreement to sell its Off-Highway business for a $2.7 billion purchase price. For shareholders, the filing also describes a $1 billion capital return authorization and about $600 million of planned 2025 returns.
Q2 2025 sales of $1.95 billion vs. $2.05 billion a year earlier; loss before tax of $24 million vs. $53 million
Full-year 2025 continuing-operations guidance: sales of $7.25 billion to $7.55 billion and adjusted EBITDA of $540 million to $610 million
Off-Highway sale: $2.7 billion purchase price, $2.4 billion net cash proceeds, expected to close late in the fourth quarter of 2025
Repurchased 14.6 million shares in Q2; $1 billion capital return authorization with about $600 million expected in 2025
LGI Homes reported second-quarter 2025 home sales revenues of $483.5 million, down from $602.5 million a year earlier, and net income of $31.5 million, or $1.36 per diluted share, versus $58.6 million, or $2.48, in the prior-year quarter. The company withdrew its full-year 2025 guidance and issued outlook only for the third quarter, citing limited visibility into the fourth quarter for its spec-focused model.
Q2 2025 home sales revenues were $483.5 million, versus $602.5 million in Q2 2024; home closings were 1,323, versus 1,655.
Q2 2025 net income was $31.5 million, or $1.36 diluted EPS, versus $58.6 million, or $2.48, a year earlier.
The company withdrew full-year 2025 guidance and expects third-quarter 2025 closings between 1,100 and 1,300.
The company repurchased 367,568 shares for $20.6 million in Q2 2025; total liquidity was $322.6 million at June 30, 2025.
NNN REIT reported second quarter 2025 revenue of $226.8 million, up from $216.8 million a year earlier, and diluted net earnings of $0.54 per share, down from $0.58. Core FFO per share rose to $0.84 from $0.83, and the company raised its 2025 Core FFO and AFFO per share guidance, though its net earnings per share guidance (excluding certain gains, impairments and severance costs) was lowered. Shareholders get higher operating-based per-share measures and a 3.4% dividend increase, but lower reported GAAP earnings per share.
Q2 2025 revenue $226.8 million vs. $216.8 million in Q2 2024; diluted net earnings $0.54 per share vs. $0.58
Q2 2025 Core FFO per share $0.84 (vs. $0.83) and AFFO per share $0.85 (vs. $0.84)
2025 Core FFO per share guidance raised to $3.34-$3.39 from $3.33-$3.38; net earnings per share guidance lowered to $1.93-$1.98 from $1.97-$2.02
Third quarter 2025 dividend raised 3.4% to $0.60 per share, the 36th consecutive annual increase
Uniti Group reported second quarter 2025 revenue of $300.7 million, up from $294.9 million a year earlier, but posted a net loss of $10.7 million compared with net income of $17.6 million in the same period of 2024. The company also completed its merger with Windstream on August 1, 2025, and updated its full-year 2025 outlook to include Windstream's expected results for the five months after closing.
Q2 2025 revenue was $300.7 million versus $294.9 million in Q2 2024; net loss to common shareholders was $10.7 million, or $0.04 per diluted share, compared with a profit of $0.07 per share a year earlier.
Adjusted EBITDA was $242.6 million, and AFFO was $0.36 per diluted share for the quarter.
Windstream merger closed August 1, 2025; Legacy Uniti shareholders hold about 62% of the company's common stock and Windstream shareholders about 38%.
Full-year 2025 outlook: revenue of $2,215 million to $2,265 million, net loss attributable to common shareholders of $125 million to $75 million, and Adjusted EBITDA of $1,110 million to $1,160 million.
Fox Corporation reported results for the quarter and fiscal year ended June 30, 2025, with fourth-quarter revenue up 6% to $3.29 billion and net income attributable to Fox stockholders of $717 million ($1.57 per share), compared with $319 million ($0.68 per share) a year earlier. The company also raised its share repurchase authorization by $5 billion to $12 billion and increased its semi-annual dividend to $0.28 per share, which matters to shareholders because it returns more cash to them.
Q4 revenue of $3.29 billion, up $195 million or 6% from the prior year quarter; adjusted EBITDA of $939 million, up 21%
Full-year revenue of $16.30 billion, up 17%; net income attributable to Fox stockholders of $2.26 billion ($4.91 per share) versus $1.50 billion ($3.13 per share)
Board raised the share repurchase authorization by $5 billion, bringing the total to $12 billion; about $250 million of Class A stock was repurchased in the quarter
Semi-annual dividend increased to $0.28 per share, payable September 24, 2025, to holders of record on September 3, 2025
IPG Photonics reported second quarter 2025 results for the period ended June 30, 2025. Revenue fell 3% year over year to $250.7 million, and GAAP net income dropped 67% to $6.6 million, while the company guided third quarter 2025 revenue to $225 million to $255 million and adjusted EPS to $0.05 to $0.35.
Q2 2025 GAAP operating income was $0.1 million, down from $12.0 million in Q2 2024; GAAP diluted EPS was $0.16 versus $0.45.
Q2 2025 adjusted EPS was $0.30 versus $0.52 a year earlier, and adjusted EBITDA was $31.5 million versus $39.4 million.
Q3 2025 guidance: revenue of $225 million to $255 million, adjusted EPS of $0.05 to $0.35, and adjusted EBITDA of $22 million to $36 million.
During Q2 2025 the company spent $30 million on share repurchases and $15 million on capital expenditures.
Knife River reported second-quarter 2025 revenue of $833.8 million, up 3%, but net income fell 35% to $50.6 million and diluted EPS fell to $0.89 from $1.37. The company revised full-year 2025 adjusted EBITDA guidance to $475 million to $525 million, citing wet weather, weak demand in Oregon and July flooding in Texas, which matters to shareholders because it reflects a weaker outlook for the year.
Q2 revenue $833.8 million, up 3% from $806.9 million; adjusted EBITDA $140.8 million, down 9%
Net income $50.6 million versus $77.9 million a year earlier; diluted EPS $0.89 versus $1.37
Record backlog of $1.3 billion at June 30, 2025, up nearly 30% from a year earlier
Full-year 2025 adjusted EBITDA guidance set at $475 million to $525 million
Organon reported second-quarter 2025 revenue of $1.594 billion, down 1% from a year earlier, and GAAP diluted earnings per share of $0.56 versus $0.75. The company raised its full-year 2025 revenue guidance to $6.275 billion to $6.375 billion, while affirming its Adjusted EBITDA margin range of 31.0% to 32.0%.
Q2 2025 revenue was $1.594 billion versus $1.607 billion in Q2 2024; net income was $145 million versus $195 million.
Non-GAAP Adjusted diluted EPS was $1.00 versus $1.12; GAAP diluted EPS of $0.56 includes a $46 million gain on early debt extinguishment.
Full-year 2025 revenue guidance rose to $6.275 billion to $6.375 billion from $6.125 billion to $6.325 billion, based on current foreign exchange views.
The company repaid $345 million of long-term debt in the quarter and is on track for a net debt to Adjusted EBITDA ratio below 4.0x by year-end.
Zebra Technologies reported second-quarter 2025 results for the quarter ended June 28, 2025, with net sales up 6.2% to $1.29 billion and non-GAAP diluted EPS up 13.5% to $3.61, while GAAP net income was roughly flat at $112 million. The company raised its full-year 2025 sales growth outlook to 5% to 7% and its adjusted EBITDA margin outlook to 21% to 22%, and it agreed to acquire Elo Touch Solutions for $1.3 billion, expected to close in 2025 and not included in its outlook.
Net sales were $1,293 million, up 6.2% year over year; GAAP net income was $112 million, or $2.19 per diluted share, versus $2.17 a year earlier.
Non-GAAP diluted EPS was $3.61 versus $3.18; gross margin fell to 47.6% from 48.4%, mainly due to about $10 million of U.S. import tariff expense net of mitigating actions.
Full-year 2025 sales growth is now expected at 5% to 7%, non-GAAP diluted EPS at $15.25 to $15.75, and free cash flow at more than $800 million.
Zebra agreed to acquire Elo Touch Solutions, Inc. for $1.3 billion, with closing expected in 2025.
Frontdoor reported second-quarter 2025 revenue up 14% to $617 million and net income up 21% to $111 million, with diluted EPS of $1.48 versus $1.18. The company raised its full-year 2025 revenue, gross profit margin and Adjusted EBITDA ranges and increased its 2025 share repurchase target to approximately $250 million.
Q2 2025 revenue $617 million, up 14%, with 2-10 acquisition a main driver of volume growth
Diluted EPS $1.48 versus $1.18 a year earlier; Adjusted EBITDA $199 million, up 26%
Full-year 2025 Adjusted EBITDA range raised to $530 million to $550 million; revenue range raised to $2.055 billion to $2.075 billion
Share repurchases totaled $150 million year-to-date through July 2025; 2025 target raised to approximately $250 million
Westlake reported a second-quarter 2025 net loss of $142 million, or $1.11 per diluted share, compared with net income of $313 million, or $2.40 per share, a year earlier. Net sales fell to $2.95 billion from $3.21 billion, and the results include $130 million of charges tied to closing the Pernis facility in The Netherlands and pausing a PVC unit in China. Excluding these items, the net loss was $12 million, or $0.09 per share, and the company expanded its cost-reduction target to an additional $200 million by 2026.
Net sales of $2,953 million in Q2 2025, down from $3,207 million in Q2 2024 but up from $2,846 million in Q1 2025.
Net loss of $142 million, or $1.11 per diluted share; excluding $130 million of identified items, net loss was $12 million, or $0.09 per share.
EBITDA excluding identified items was $340 million, compared with $744 million in Q2 2024 and $288 million in Q1 2025.
Cost-reduction target expanded to an additional $200 million of reductions by 2026, on top of a 2025 target of $150 million to $175 million.
Enpro reported second-quarter 2025 sales of $288.1 million, up 6.0%, while net income was $26.4 million versus $26.7 million a year earlier and adjusted diluted EPS fell 2.4% to $2.03. The company raised its full-year 2025 guidance, now expecting adjusted EBITDA of $270 million to $280 million and adjusted diluted EPS of $7.60 to $8.10, compared with prior ranges of $262 million to $277 million and $7.00 to $7.70. Higher sales were offset by growth-related operating expenses and foreign exchange headwinds, so shareholders see revenue and guidance improving alongside lower quarterly profit.
Q2 2025 sales of $288.1 million, up 6.0%; adjusted EBITDA of $71.1 million versus $74.0 million, down 3.9%
Diluted EPS of $1.25 versus $1.27; adjusted diluted EPS of $2.03 versus $2.08
Full-year 2025 adjusted EBITDA guidance raised to $270 million-$280 million from $262 million-$277 million
Quarterly dividend of $0.31 per share declared July 31, 2025, payable September 17, 2025
AdaptHealth reported second quarter 2025 net revenue of $800.4 million, down 0.7% from $806.0 million, and net income attributable to the company of $14.7 million, down from $19.4 million. The company lowered its full-year 2025 Adjusted EBITDA guidance to $642 million to $682 million from $662 million to $702 million, which matters to shareholders because both headline profit and the outlook weakened.
Net revenue was $800.4 million versus $806.0 million a year earlier, a decrease of 0.7%.
Adjusted EBITDA was $155.5 million versus $165.3 million, a decrease of 5.9%.
Full-year 2025 Adjusted EBITDA guidance was lowered to $642 million to $682 million from $662 million to $702 million.
Full-year 2025 net revenue guidance was narrowed to $3.18 billion to $3.26 billion from $3.15 billion to $3.29 billion; free cash flow guidance of $170 million to $190 million was unchanged.
Archer-Daniels-Midland reported second-quarter 2025 results, with GAAP diluted EPS of $0.45 and adjusted EPS of $0.93, down 54% and 10% from the prior-year quarter. The company also narrowed its full-year 2025 adjusted EPS guidance to approximately $4.00 per share, based on first-half performance and expected margin benefits in the fourth quarter and beyond. For shareholders, lower earnings and a lower outlook point to weaker profitability, with management citing biofuel policy uncertainty and a challenging Ag Services and Oilseeds environment.
Q2 2025 net earnings attributable to ADM were $219 million, versus $486 million a year earlier; revenues were $21.2 billion, versus $22.2 billion.
Total segment operating profit was $830 million, down 10%; Ag Services and Oilseeds profit fell 17% to $379 million, and Crushing profit fell 75% to $33 million.
Full-year 2025 adjusted EPS guidance was tightened to approximately $4.00 per share.
Year-to-date operating cash flow was $4.0 billion, and the company said it remediated a previously identified material weakness related to segment disclosures.
Zoetis reported second-quarter 2025 revenue of $2.5 billion, up 4% on a reported basis and 8% on an organic operational basis, and net income of $718 million, or $1.61 per diluted share, up 15% and 18%. The company raised its full-year 2025 revenue guidance to $9.450 billion to $9.600 billion and its adjusted diluted EPS guidance to $6.30 to $6.40, which is the main change for shareholders.
Q2 2025 revenue was $2.5 billion, with U.S. segment revenue of $1.4 billion and International segment revenue of $1.1 billion.
Q2 2025 net income was $718 million, or $1.61 per diluted share; adjusted net income was $783 million, or $1.76 per diluted share.
Full-year 2025 adjusted diluted EPS guidance rose to $6.30 to $6.40 from $6.20 to $6.30; reported diluted EPS guidance is $5.90 to $6.00.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.